Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: MoneyMade who wrote (8722)	11/5/1998 10:17:00 PM
From: GT	Read Replies (2) \| Respond to of 119973

What did they say ??? Going to $25 tomorrow !!!!!!

To: MoneyMade who wrote (8722)	11/5/1998 10:20:00 PM
From: FawnVu	Read Replies (1) \| Respond to of 119973

GERN and GERN...Just borrow an interesting post from Yahoo: Those of you spreading negative or deflating news about GERN are obviously short, or you wouldn't bother insulting our intelligence with baseless conclusions. The facts are that Geron Corporation owns an exclusive worldwide license to market any and all applications deriving from their funding of a major medical breakthrough announced today after the close. To call it revolutionary is not an understatement. If this were not the case, then why would all three national television networks carry the story immediately after the announcement on their primetime news telecasts? Not 60 minutes or Nightline, or some "Technology Week" special, but on their most prestigious timeslot. That says quite a bit about what television exectuvies deem to be the worth of the University of Wisconsin and Johns Hopkins studies made public today. This news has been much more widely disseminated than the Entremed story, which was merely an article in the New York Times. Granted, the mania inherent in the markets May 4, when it opened at 85, from 12 the previous day, is not at such a fever pitch today, but it is still there. Witness KTEL's run-up Tuesday. There are some interesting parallels to KTEL as well. KTEL had a very high short ratio, which led to a surge of short-covering, which added fuel to the fire. GERN has a short ratio of 4.0, and it did not look as if many shorts were covering today. Otherwise, it would have closed at it's intraday high, which it did not. It was obvious that some traders were still shorting, believe it or not. Also, Tuesday morning there were no KTEL shares available for purchase on Instinet. This afternoon there were likewise no shares of GERN available on Instinet. That means institutions and professionals were not selling at any price, obviously a very positive indication. It became clear to me where GERN was headed when, for those of you who have access to Level II, JPMS (J. P. Morgan & Company), the axe, or most influential market maker in the stock, was chasing the bid, headfaking to the ask - doing all he could to buy up all available shares, a sure sign of a gap. I doubled my position when JPMS' heavy buying became clear. 85 tomorrow morning would be quite a gap, but anything is possible. Due to the saturation coverage GERN has received this afternoon and evening, and the no-doubt media blitz in all the morning papers it will enjoy tomorrow, I expect there will be an incredible degree of buying pressure on GERN. This is solid, spectacular, confirmed news, not a rumor. The market knows this, and will react accordingly. Volume will probably be somewhere in the 20-30 million range, at least. Johns Hopkins, one of America's preeminent and most prestigious hospitals, was involved in this study, and the results would not have been announced unless they were absolutely unassailable. The conference call of this afternoon by Geron's CEO, which I heard in its entirety, was very impressive. He answered some very insightful questions with confidence and vigor. I have expected great things from his company for some time now, and that patience is finally paying off. After Greenspan's positive remarks today, and the Dow's subsequent 150-point rally into the close, I expect the environment to be ripe for a tremendous surge in the price of Geron stock tomorrow, all day long. Whether that means $40 or $90, we will just have to wait and see.